Search research articles
Contact Us
Filters
Showing results (261-270 of 420) with videos related to
Page
of 42
Sort By:
World Journal of Urology
|
March 29, 2022
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
Mattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, et al.
World Journal of Urology
|
December 7, 2018
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials
Matteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, et al.
Prostate Cancer and Prostatic Diseases
|
December 15, 2019
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
Stefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
Medicine
|
June 15, 2017
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study
Davide Bosso, Martina Pagliuca, Guru Sonpavde, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2023
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score
Gennaro Musi, Stefano Luzzago, Giovanni Mauri, et al.
Prostate Cancer and Prostatic Diseases
|
September 29, 2020
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort
Stefano Luzzago, Ottavio de Cobelli, Francesco A Mistretta, et al.
Cancers
|
March 28, 2024
Upper Tract Urothelial Cancer: Guideline of Guidelines
Savio Domenico Pandolfo, Simone Cilio, Achille Aveta, et al.
BJU International
|
March 10, 2020
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings
Stefano Luzzago, Ottavio de Cobelli, Gabriele Cozzi, et al.
Journal of Clinical Medicine
|
April 26, 2025
Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer?
Giovanni Tarantino, Ciro Imbimbo, Matteo Ferro, et al.
Critical Reviews in Oncology/Hematology
|
July 25, 2025
Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncology
Matteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 420) with videos related to
Sort By:
Page
of 42
World Journal of Urology
|
March 29, 2022
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
Mattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, et al.
World Journal of Urology
|
December 7, 2018
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials
Matteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, et al.
Prostate Cancer and Prostatic Diseases
|
December 15, 2019
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
Stefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
Medicine
|
June 15, 2017
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study
Davide Bosso, Martina Pagliuca, Guru Sonpavde, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2023
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score
Gennaro Musi, Stefano Luzzago, Giovanni Mauri, et al.
Prostate Cancer and Prostatic Diseases
|
September 29, 2020
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort
Stefano Luzzago, Ottavio de Cobelli, Francesco A Mistretta, et al.
Cancers
|
March 28, 2024
Upper Tract Urothelial Cancer: Guideline of Guidelines
Savio Domenico Pandolfo, Simone Cilio, Achille Aveta, et al.
BJU International
|
March 10, 2020
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings
Stefano Luzzago, Ottavio de Cobelli, Gabriele Cozzi, et al.
Journal of Clinical Medicine
|
April 26, 2025
Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer?
Giovanni Tarantino, Ciro Imbimbo, Matteo Ferro, et al.
Critical Reviews in Oncology/Hematology
|
July 25, 2025
Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncology
Matteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, et al.
Page
of 42